Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 241–300 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…6 patients were on antihistamines or montelukast and 5 received dupilumab. PD-L1 expression was available for 17 patients with a median e…
…on E, Sondak VK, Ribas A. Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N Engl J Med. 2023 Mar 2;388(9):813-823.B…
…, Rimm DL, Chuang JH, Reisenbichler E, Zarringhalam K. HER2 and trastuzumab treatment response H&E slides with tumor ROI annotations (Versi…
… high-affinity FDA-approved inhibitors for IL6R and EGFR (e.g., tocilizumab and erlotinib), as well as PAM analogs targeting mGluR7. Logic …
…(42.6%) did not. The most frequently administered regimens were ipilimumab, nivolumab, and pembrolizumab, with or without platinum-based c…
…jection while aged mice were treated with an inhibitor of ARG1, Numidargistat (CB-1158, 100 mg/kg/mouse), given via oral gavage twice daily. …
…and Prof Alison Hulme without whose design and synthesis of the cyclophilin inhibitors, this work would not be possible. Thanks are also extended to D…
…heckpoint inhibitors (ICIs) in lung cancer patients. Currently, ICIs are the most effective treatment for late-stage lung cancer; ho…
…17;389(10066):255–265.Socinski MA, Jotte RM, Cappuzzo F, et al. Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. N Eng…
…primates, 2) enhanced killing when IdeS-pretreated mAbs such as trastuzumab were exposed to cancer cell lines in the presence of IVIg plus …
…tract 1229 Figure 1NF-κB signaling is associated with increased CCL20 (A) and increased anti-tumor lymphocytes (specifically effector…